Enzyme

Enzyme is a company that provides advanced electronic Quality Management System (eQMS) software tailored for life science companies. Founded in 2017 and headquartered in South San Francisco, Enzyme was established by industry veterans who were dissatisfied with existing QMS solutions. The company serves a diverse range of clients, from startups to large enterprises, helping them streamline their quality processes and ensure compliance from premarket to postmarket stages. Enzyme's eQMS software is designed to be flexible and scalable, adapting to the specific needs of each client rather than forcing them to conform to a rigid system. This adaptability makes it suitable for companies at various stages of growth, including those preparing for an Initial Public Offering (IPO). The business operates in the life sciences market, focusing on companies involved in biotechnology, pharmaceuticals, and medical devices. Enzyme's business model revolves around providing software as a service (SaaS), generating revenue through subscription fees. The company also offers expert in-house consulting services to help clients optimize their quality management processes. Enzyme's mission is to empower life science companies to innovate more efficiently and effectively by providing a robust framework for setting and meeting quality objectives. The company's commitment to continuous improvement ensures that its eQMS software evolves to meet the changing needs of its clients.

Keywords: eQMS, life sciences, quality management, compliance, biotechnology, pharmaceuticals, medical devices, SaaS, consulting, innovation.